The FDA committee recommends limiting the Pfizer booster dose to the elderly

The FDA committee recommends limiting the Pfizer booster dose to the elderly

Photo: Mike Sena / MS

An FDA Scientific Advisory Committee, “USA Visa”, This Friday (17th) Pfizer Vaccine Booster dose is recommended for adults over 65 years of age and those at high risk of developing severe symptoms of Kovid..

Hours earlier, the same committee had advised Pfizer not to give this booster dose to people over the age of 16 by 2 votes to 2. According to the New York Times, there was “Intense public debate” Do you need a vaccine booster, and if so, for whom.

During the committee’s discussion, many of the independent experts, including epidemiologists and statisticians, questioned whether the data would justify additional doses for the majority of the population when immunizations still seem to provide strong protection against Kovid infection and hospitalization.

It is not clear whether everyone needs booster shots except a subset of the population at high risk for serious illness., Said Michael G. Curilla, a board member and official at the National Institutes of Health.

Although the FDA is not required to accept the recommendations of its advisory board, they are generally followed. The agency is expected to make a decision on the matter early next week.

More news

See also  Los Angeles police respond to shootings in middle schools and kindergartens; Injured there | The world
Written By
More from Cheryl Hines
The U.S. Border Guard uses horse bridles to drive out Haitian immigrants
WASHINGTON – U.S. border patrol agents are on horseback trying to stop...
Read More
Leave a comment

Your email address will not be published. Required fields are marked *